Vivos Therapeutics, Inc. Shares Jump After FDA Grants Market Clearance for treatment of Mild to Moderate Sleep Apnea
Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares jumped about 50% after the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Vivos’ mmRNA (modified mandibular Repositioning Nighttime Appliance) device for treating mild to moderate OSA, sleep-disordered breathing and...